Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
06/11/2025
Reserve Bank of New Zealand Governor Adrian Orr: New Zealand's financial system is in a favorable position to cope with more severe situations.
Latest
1 m ago
Qualcomm: Apple, Samsung, and China's Xiaomi currently each account for over 10% of its revenue.
2 m ago
"Longest in history" Spring Festival holiday stimulates A-shares tourism market.
2 m ago
Cross-border trading: Plans to allocate 16.66 million H shares.
3 m ago
Household appliance companies and car companies frequently "get married", accelerating the race to seize the entrance to the full scene.
3 m ago
According to The Wall Street Journal, on November 5th, Pfizer is preparing to once again increase its acquisition offer for Merck in the United States Eastern Time. Pfizer initially reached an agreement in September to acquire Merck for $4.9 billion. On October 30th, Novo Nordisk's acquisition offer shocked Wall Street and Pfizer, leading to further competition between the two pharmaceutical giants. Judge Morgan Zahn of the Delaware Chancery Court ruled on Wednesday that Pfizer did not raise any reasonable objections to Novo Nordisk's attempt to replace it as the acquirer of Merck, based in New York, and therefore refused to block the Danish company from continuing with the deal. Pfizer had raised its initial acquisition offer earlier this week and is currently working on multiple fronts to maintain control of Merck. Novo Nordisk agrees with the court's ruling and believes its acquisition offer is in the best interest of Merck shareholders.
See all latest